☆ 4.0 Article

Histone deacetylase inhibitors: Development of suberoylanilide hydroxamic acid (SAHA) for the treatment of cancers

BLOOD CELLS MOLECULES AND DISEASES (2001)

Get Full Text
Add to Collection

Journal

BLOOD CELLS MOLECULES AND DISEASES
Volume 27, Issue 1, Pages 260-264

Publisher

ACADEMIC PRESS INC
DOI: 10.1006/bcmd.2000.0376

Keywords

-

Categories

Hematology

Funding

  1. NCI NIH HHS [CA-84292-01, CA-0974823] Funding Source: Medline
  2. NATIONAL CANCER INSTITUTE [U01CA084292] Funding Source: NIH RePORTER

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.0
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.